home / stock / srpt / srpt articles

SRPT Articles, Sarepta Therapeutics Inc. - From 06/21/24

Stock Information
Company Name: Sarepta Therapeutics Inc.
Stock Symbol: SRPT
Market: NASDAQ
Website: sarepta.com
Menu
SRPT SRPT Quote SRPT Short SRPT News SRPT Articles SRPT Message Board
Get SRPT Alerts

News, Short Squeeze, Breakout and More Instantly...
Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday | Benzinga

U.S. stocks were mixed, with the Dow Jones index gaining around 50 points on Friday. Shares of Asana, Inc. (NYSE:ASAN) rose sharply during Friday&#...
Apple To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Friday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) rose sharply in today's pre-market trading after the company announced expanded US FDA appr...

FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy | Benzinga

Thursday, the FDA approved labeled indication for Sarepta Therapeutics Inc’s (NASDAQ:SRPT) Elevidys (delandistrogene moxeparvovec-rokl) to in...
Wall Street Looks Set For Modestly Lower Start Ahead Of Key Data, Tech Stocks Muted In Premarket: Analyst Says 'Bearish Sentiment Has Become Understandably Quiet' | Benzinga

Wall Street is on track for a lackluster open after the S&P 500’s back-to-back record performances in the first two sessions of the week....

Pfizer Phase III DMD Gene Therapy Study Misses Goal | Benzinga

Pfizer (NYSE: PFE) announced that a phase III study on its mini-dystrophin gene therapy fordadistrogene movaparvovec for treating Duchenne muscular...

Why Sarepta Therapeutics Stock Is Rising Today | Benzinga

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stock is trading higher on Thursday after it was announced the company will be added to the S&P MidCap...
With FDA Decision Date Approaching, Analyst Downgrades Sarepta On Balanced Risk And Reward | Benzinga

RBC Capital Markets has downgraded Sarepta Therapeutics Inc (NASDAQ:SRPT) as it weighs recent investor feedback, company commentary, and public s...

Sarepta Downgraded As FDA Decision Date Approaches, Shares Up 50% Over Last Six Months | Benzinga

RBC Capital Markets has downgraded Sarepta Therapeutics Inc (NASDAQ:SRPT) as it weighs recent investor feedback, company commentary, and ...

Jim Cramer: This Industrial Stock Is Doing 'Very Well'; Here's His Take On Palantir | Benzinga

On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Enbridge Inc. (NYSE:ENB). “I trust that management team,R...
Previous 10 Next 10